Ad is loading...
RSLAX
Price
$57.69
Change
-$0.71 (-1.22%)
Updated
Nov 15 closing price
RSLEX
Price
$68.12
Change
-$0.84 (-1.22%)
Updated
Nov 15 closing price
Ad is loading...

RSLAX vs RSLEX

Header iconRSLAX vs RSLEX Comparison
Open Charts RSLAX vs RSLEXBanner chart's image
American Funds SMALLCAP World R1
Price$57.69
Change-$0.71 (-1.22%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World R4
Price$68.12
Change-$0.84 (-1.22%)
VolumeN/A
CapitalizationN/A
RSLAX vs RSLEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RSLAX vs. RSLEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSLAX is a Buy and RSLEX is a Buy.

FUNDAMENTALS
Fundamentals
RSLAX (74.7B) and RSLEX (74.7B) have equal amount of cash in the bank . RSLEX pays higher dividends than RSLAX: RSLEX (0.65) vs RSLAX (0.35). RSLAX was incepted earlier than RSLEX: RSLAX (22 years) vs RSLEX (22 years). RSLAX (29.00) and RSLEX (29.00) have comparable annual turnover. RSLAX (250) and RSLEX (250) have matching initial minimum investment requirements. RSLEX annual gain was more profitable for investors over the last year : 16.00 vs. RSLAX (15.13). RSLEX return over 5 years is better than : 18.89 vs. RSLAX (12.12).
RSLAXRSLEXRSLAX / RSLEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years22 years-
Gain YTD3.0733.74782%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets74.7B74.7B100%
Annual Yield % from dividends0.350.6553%
Returns for 1 year15.1316.0095%
Returns for 3 years-28.49-25.86110%
Returns for 5 years12.1218.8964%
Returns for 10 years23.7739.0061%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACVA20.720.70
+3.50%
ACV Auctions
FBMS36.370.12
+0.33%
First Bancshares
HFFG3.42-0.04
-1.16%
HF Foods Group
UTHR363.25-23.02
-5.96%
United Therapeutics Corp
NLSP3.13-0.21
-6.29%
Nls Pharmaceutics Ltd